Trial of Pembrolizumab in Cancer of Unknown Primary
Clinical trial NCT03752333 · COMPLETED
Trial details
- NCT number
- NCT03752333
- Sponsor
- Imperial College London
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2025-03-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.